S&P revises Swedish Covenant Health outlook to negative

 
S&P Global Ratings revised its outlook for Chicago-based Swedish Covenant Health from stable to negative.

Advertisement

The outlook revision reflects the system’s unexpected operating margin loss in fiscal year 2018.

S&P also affirmed its “BBB” long-term issuer rating for Swedish Covenant Health.

More articles on healthcare finance:

Pennsylvania hospital’s payroll troubles persist
CFO Ben Spence on Lee Health’s transformation
Congress takes up surprise medical bills: 7 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.